Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) Shares Outstanding (Weighted Average) (2018 - 2025)

Health Catalyst's Shares Outstanding (Weighted Average) history spans 8 years, with the latest figure at $69.9 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 16.14% year-over-year to $69.9 million; the TTM value through Dec 2025 reached $69.9 million, up 16.14%, while the annual FY2025 figure was $69.9 million, 16.14% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $69.9 million in Q4 2025 per HCAT's latest filing, up from $69.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $69.9 million in Q4 2025 to a low of $43.9 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $56.8 million, with a median of $56.0 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Weighted Average): grew 20.83% in 2022, then grew 3.24% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $47.5 million in 2021, then increased by 13.11% to $53.7 million in 2022, then grew by 5.02% to $56.4 million in 2023, then grew by 6.68% to $60.2 million in 2024, then rose by 16.14% to $69.9 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Shares Outstanding (Weighted Average) are $69.9 million (Q4 2025), $69.5 million (Q3 2025), and $69.1 million (Q2 2025).